Back
Duos Technologies Group Vs. Novo Nordisk AS Industry Stock Comparison
Sell
29
DUOT
Duos Technologies Group
Last Price:
$6.28
Seasonality Move:
-17.77%
Sell
19
NVO
Novo Nordisk AS
Last Price:
$49.79
Seasonality Move:
0.99%
Sell
29
Duos Technologies Group (DUOT)
is a Sell
Is Duos Technologies Group a Buy, Sell or Hold?
-
The current Duos Technologies Group [DUOT] share price is $6.06. The Score for DUOT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
DUOT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $49.87. The Score for NVO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DUOT Stock Price Chart
What is Duos Technologies Group's stock price today?
-
The Duos Technologies Group share price today is $6.06The current trend is moderately bullish and DUOT is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $49.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
DUOT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.77 | Buy |
Relative Strength Index (14 RSI): | 32.72 | Sell |
Chaikin Money Flow: | -276502 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.76 - 7.98) | Sell |
Bollinger Bands (100): | (5.88 - 8.04) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.46 | Buy |
Relative Strength Index (14 RSI): | 34.62 | Sell |
Chaikin Money Flow: | -13317497 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.9 - 70.34) | Sell |
Bollinger Bands (100): | (59.26 - 74.24) | Sell |
DUOT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.62 | Sell |
20-day SMA: | 7.33 | Sell |
50-day SMA: | 7.53 | Sell |
200-day SMA: | 6.24 | Sell |
8-day EMA: | 6.02 | Buy |
20-day EMA: | 4.23 | Buy |
50-day EMA: | 2.23 | Buy |
200-day EMA: | 0.65 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.3 | Buy |
20-day SMA: | 58.37 | Sell |
50-day SMA: | 66.7 | Sell |
200-day SMA: | 80.62 | Sell |
8-day EMA: | 45.05 | Buy |
20-day EMA: | 30.95 | Buy |
50-day EMA: | 16.15 | Buy |
200-day EMA: | 4.66 | Buy |
Duos Technologies Group Earnings Growth & DUOT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.76 per share, and an increase next year of $0.55 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.18 per share, an increase this year of $0.78 per share, and an increase next year of $0.35 per share.
Duos Technologies Group Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |